Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Imax Corp. buy Barrington Research

Start price
€16.10
28.02.24 / 50%
Target price
€22.13
28.02.25
Performance (%)
0.00%
Price
€15.50
25.04.24
Summary
This prediction is currently active. The BUY prediction by Barrington_Research is currently unchanged from the start price. This prediction currently runs until 28.02.25. The prediction end date can be changed by Barrington_Research at any time. Barrington_Research has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Imax Corp. -3.125% -3.125%
iShares Core DAX® 2.594% -1.158%
iShares Nasdaq 100 3.553% -1.727%
iShares Nikkei 225® 0.687% -8.354%
iShares S&P 500 2.209% -0.942%

Comments by Barrington_Research for this prediction

In the thread Imax Corp. diskutieren
Prediction Buy
Perf. (%) 0.00%
Target price 22.128
Change
Ends at 28.02.25

IMAX Co. (NYSE: IMAX) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $24.00 price target on the stock.
Ratings data for IMAX provided by MarketBeat

Stopped prediction by Barrington_Research for Imax Corp.

buy
Imax Corp.

Start price
Target price
Perf. (%)
€16.20
22.04.24
€22.55
22.04.25
-0.62%
25.04.24

buy
Imax Corp.

Start price
Target price
Perf. (%)
€16.80
28.07.23
€21.81
28.07.24
-7.74%
25.04.24

buy
Imax Corp.

Start price
Target price
Perf. (%)
€18.30
21.04.23
€21.86
21.04.24
-12.02%
22.04.24